BlossomHill Therapeutics, Inc. (BLSM) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 6 insider purchases totalling $25.2M. Most recent filing: Aug. 12, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 12, 2026 filed Aug. 10, 2026 | GORDON CARL L Director | +$10,000,000 | 4,803,558 | — | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 10, 2026 | ORBIMED ADVISORS LLC Director | +$10,000,000 | 4,803,558 | — | No | |
|
|
||||||
| Aug. 10, 2026 | Schmid John P. Director | +$96,000 | 6,000 | New | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | GORDON CARL L Director | $0 | 23,904 | 0% | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Chen Bihua Director | +$5,000,000 | 6,939,472 | — | No | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free